ISLR-2 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-91341
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Synthetic peptide directed towards the N terminal of human ISLR2. Peptide sequence PFHCGCGLVWLQAWAASTRVSLPEPDSIACASPPALQGVPVYRLPALPCA. The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Description
The addition of 50% glycerol is optional for those storing this antibody at -20C and not aliquoting smaller units. However, please note that glycerol may interrupt some downstream antibody applications and should be added with caution.
Scientific Data Images for ISLR-2 Antibody
![Western Blot: ISLR-2 Antibody [NBP1-91341]](https://resources.bio-techne.com/images/products/ISLR-2-Antibody-Western-Blot-NBP1-91341-img0002.jpg "Western Blot: ISLR-2 Antibody [NBP1-91341]")
Western Blot: ISLR-2 Antibody [NBP1-91341]
Western Blot: ISLR-2 Antibody [NBP1-91341] - Hela cell lysate, concentration 0.2-1 ug/ml.Applications for ISLR-2 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: ISLR-2
Long Name
Immunoglobulin Superfamily Containing Leucine-rich Repeat 2
Alternate Names
ISLR2
Gene Symbol
ISLR2
UniProt
Additional ISLR-2 Products
Product Documents for ISLR-2 Antibody
Product Specific Notices for ISLR-2 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...